You turn to us for voices you won't hear anywhere else.

Sign up for Democracy Now!'s Daily Digest to get our latest headlines and stories delivered to your inbox every day.

Pfizer Asks for FDA Approval of Omicron-Specific Booster Shot

HeadlineAug 23, 2022

Pfizer and BioNTech have asked the FDA to approve a new version of its COVID-19 vaccine that targets mutated forms of the coronavirus. Pfizer’s updated shot is based on both the original virus that first emerged in 2019, as well as the BA.4 and BA.5 Omicron subvariants that now account for nearly all U.S. cases. Pfizer submitted its application without completing a new clinical trial, meaning it’s not clear whether the updated vaccine will provide more protection. mRNA vaccines produced by Pfizer and Moderna remain highly effective at preventing severe disease and death from COVID but are much less effective at preventing infection and mild disease.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation